SG Americas Securities LLC boosted its position in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) by 6.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,392 shares of the company’s stock after purchasing an additional 193 shares during the quarter. SG Americas Securities LLC’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $305,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the third quarter valued at $43,000. Dunhill Financial LLC bought a new position in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at about $46,000. B. Riley Wealth Advisors Inc. acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter valued at about $279,000. Foundations Investment Advisors LLC raised its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 13.0% during the 3rd quarter. Foundations Investment Advisors LLC now owns 4,617 shares of the company’s stock worth $594,000 after buying an additional 530 shares in the last quarter. Finally, McGuire Investment Group LLC lifted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 3.9% in the 3rd quarter. McGuire Investment Group LLC now owns 4,633 shares of the company’s stock worth $596,000 after acquiring an additional 175 shares during the period.
Direxion Daily S&P Biotech Bull 3x Shares Trading Up 3.6 %
Direxion Daily S&P Biotech Bull 3x Shares stock opened at $95.15 on Wednesday. Direxion Daily S&P Biotech Bull 3x Shares has a 12-month low of $78.46 and a 12-month high of $176.99. The firm has a 50 day simple moving average of $100.24 and a 200-day simple moving average of $118.46.
Direxion Daily S&P Biotech Bull 3x Shares Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Recommended Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Basic Materials Stocks Investing
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- What Does Downgrade Mean in Investing?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- What is Short Interest? How to Use It
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.